China Tops Growth In Non-Prescription Drugs
This article was originally published in PharmAsia News
Executive Summary
At Beijing's recent International Pharmaceutical Federation World Self-Medication Industry Symposium, figures showed that as of Q2 2008, China's average growth rate of non-prescription drug revenue ranked first in the world over the past three years. According to the latest study jointly conducted by Nicholas Hall & Company and Jowin Communications, China's non-prescription drug sales hit $7.3 billion in 2007 and maintain an annual growth rate of roughly 11 percent, far higher than that of the world's average rate of 5.4 percent. Experts point out that non-prescription drugs have huge room for expansion, with market value of the sector expected to exceed $16.3 billion by 2017. (Click here for more - Chinese Language)